149 related articles for article (PubMed ID: 35657175)
1. Retraction: The
Zeng P; Chai Y; You C; Yue L; Wu C; Chen H; Li L; Li J; Liu H; Zhang Y; Cao T; Li Y; Hu W
Turk J Haematol; 2022 Aug; 39(3):188-195. PubMed ID: 35657175
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of Relationship between Long Non-Coding RNA Small Nucleolar RNA Host Gene 1 and Acute Myeloid Leukemia Risk and Prognosis in Pediatric Patients].
Su W; Hong Y; Jiang H
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1127-1136. PubMed ID: 32798387
[TBL] [Abstract][Full Text] [Related]
3. IncRNA MVIH correlates with disease features, predicts treatment response and survival in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Gao C; Duan Y; Ren Y; Zhang H; Liu J; Gao W
J Clin Lab Anal; 2021 Apr; 35(4):e23739. PubMed ID: 33704838
[TBL] [Abstract][Full Text] [Related]
4. Lnc-SOX6-1 upregulation correlates with poor risk stratification and worse treatment outcomes, and promotes cell proliferation while inhibits apoptosis in pediatric acute myeloid leukemia.
Guan X; Wen X; Xiao J; An X; Yu J; Guo Y
Int J Lab Hematol; 2019 Apr; 41(2):234-241. PubMed ID: 30624855
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of lnc-SNHG1 and miR-216b-5p correlate with chemoresistance and indicate poor prognosis of serous epithelial ovarian cancer.
Pei ML; Zhao ZX; Shuang T
J Ovarian Res; 2020 Dec; 13(1):144. PubMed ID: 33302997
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of long non coding maternally expressed gene 3 in pediatric acute myeloid leukemia.
Xue H; Gao H; Xia H; Li S; Li N; Duan Y; Ren Y; Zhang H; Liu J; Gao W
Medicine (Baltimore); 2021 Sep; 100(35):e26959. PubMed ID: 34477125
[TBL] [Abstract][Full Text] [Related]
7. Long Noncoding RNA Maternally Expressed Gene 3 Is Downregulated, and Its Insufficiency Correlates With Poor-Risk Stratification, Worse Treatment Response, as Well as Unfavorable Survival Data in Patients With Acute Myeloid Leukemia.
He C; Wang X; Luo J; Ma Y; Yang Z
Technol Cancer Res Treat; 2020; 19():1533033820945815. PubMed ID: 32720591
[TBL] [Abstract][Full Text] [Related]
8. Long non‑coding RNA ANRIL is a potential indicator of disease progression and poor prognosis in acute myeloid leukemia.
Tan Z; Zhu K; Yin Y; Luo Z
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33300059
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MEG3 as a candidate prognostic factor for induction therapy response and survival profile in childhood acute lymphoblastic leukemia patients.
Gao W
Scand J Clin Lab Invest; 2021 May; 81(3):194-200. PubMed ID: 33600264
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia.
Zhou H; Zhang Q; Huang W; He C; Zhou C; Zhou J; Ning Y
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052262
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG1 contributes to the regulation of acute myeloid leukemia cell growth by modulating miR-489-3p/SOX12/Wnt/β-catenin signaling.
Li C; Gao Q; Wang M; Xin H
J Cell Physiol; 2021 Jan; 236(1):653-663. PubMed ID: 32592199
[TBL] [Abstract][Full Text] [Related]
12. Potentiality of Protein phosphatase Mg
Yu M; Hu J; He D; Chen Q; Liu S; Zhu X; Li B
J Clin Lab Anal; 2020 May; 34(5):e23171. PubMed ID: 31901183
[TBL] [Abstract][Full Text] [Related]
13. Correlation of long non-coding RNA taurine-upregulated gene 1 with disease conditions and prognosis, as well as its effect on cell activities in acute myeloid leukemia.
Qin J; Bao H; Li H
Cancer Biomark; 2018; 23(4):569-577. PubMed ID: 30452403
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA taurine-upregulated gene 1 correlates with unfavorable prognosis in patients with refractory or relapsed acute myeloid leukemia treated by purine analogue based chemotherapy regimens.
Luo W; Yu H; Zou X; Ni X; Wei J
Cancer Biomark; 2018; 23(4):485-494. PubMed ID: 30347595
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value and potential mechanism of long non-coding RNA Lnc-SMIM20-1 in acute myeloid leukemia.
Liu S; Sun Z; Zhu M; Liu M; Wei M; Pan X; Huang S
Expert Rev Anticancer Ther; 2022 Aug; 22(8):875-885. PubMed ID: 35894677
[TBL] [Abstract][Full Text] [Related]
16. Blood MALT1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients.
Geng H; Wang Y; Wang S
Hematology; 2022 Dec; 27(1):1176-1183. PubMed ID: 36314929
[TBL] [Abstract][Full Text] [Related]
17. Lnc-SNHG1 may promote the progression of non-small cell lung cancer by acting as a sponge of miR-497.
Li Z; Lu Q; Zhu D; Han Y; Zhou X; Ren T
Biochem Biophys Res Commun; 2018 Nov; 506(3):632-640. PubMed ID: 30454699
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA SPI1 expression before and after induction therapy and its correlation with clinical features, treatment response, and survival of acute myeloid leukemia patients.
Xiong T; Xia L; Song Q
J Clin Lab Anal; 2023 Feb; 37(3):e24835. PubMed ID: 36644997
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA taurine-upregulated gene 1 correlates with poor prognosis, induces cell proliferation, and represses cell apoptosis via targeting aurora kinase A in adult acute myeloid leukemia.
Wang X; Zhang L; Zhao F; Xu R; Jiang J; Zhang C; Liu H; Huang H
Ann Hematol; 2018 Aug; 97(8):1375-1389. PubMed ID: 29654398
[TBL] [Abstract][Full Text] [Related]
20. Identification of long non-coding RNA MVIH as a prognostic marker and therapeutic target in acute myeloid leukemia.
Jiang Z; Yu Q; Luo X
J Clin Lab Anal; 2020 Apr; 34(4):e23113. PubMed ID: 31724217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]